{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:34:25Z","timestamp":1782520465645,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Science Research Project of Hebei","award":["20250066"],"award-info":[{"award-number":["20250066"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-04032-5","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T13:19:21Z","timestamp":1760447961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["miR-1287-5p suppresses proliferation, migration, invasion and promotes apoptosis in gastric cancer cells through targeting LAMTOR3"],"prefix":"10.1186","volume":"23","author":[{"given":"Jinjia","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huadong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"4032_CR1","doi-asserted-by":"publisher","unstructured":"Freddie Bray F, Jacques S, Isabelle et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A cancer journal for clinicians. 2018; 68(6): 394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","DOI":"10.3322\/caac.21492"},{"issue":"4","key":"4032_CR2","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s10120-017-0786-6","volume":"21","author":"TD Hamilton","year":"2018","unstructured":"Hamilton TD, Mahar AL, Haas B, et al. The impact of advanced age on short-term outcomes following gastric cancer resection: an ACS-NSQIP analysis. Gastric Cancer. 2018;21(4):710\u20139. https:\/\/doi.org\/10.1007\/s10120-017-0786-6.","journal-title":"Gastric Cancer"},{"key":"4032_CR3","doi-asserted-by":"publisher","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: past, present, and future.cancer genet. 2024;286\u2013287:18\u201324. https:\/\/doi.org\/10.1016\/j.cancergen.2024.06.002","DOI":"10.1016\/j.cancergen.2024.06.002"},{"key":"4032_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117428","volume":"320","author":"L Ou","year":"2024","unstructured":"Ou L, Liu HR, Shi XY, et al. Terminalia chebula Retz. aqueous extract inhibits the Helicobacter pylori-induced inflammatory response by regulating the inflammasome signaling and ER-stress pathway. J Ethnopharmacol. 2024;320:117428. https:\/\/doi.org\/10.1016\/j.jep.2023.117428.","journal-title":"J Ethnopharmacol"},{"issue":"17","key":"4032_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e37046","volume":"10","author":"L Ou","year":"2024","unstructured":"Ou L, Liu H, Peng C, et al. Helicobacter pylori infection facilitates cell migration and potentially impact clinical outcomes in gastric cancer. Heliyon. 2024;10(17):e37046. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37046.","journal-title":"Heliyon"},{"issue":"6","key":"4032_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19061683","volume":"19","author":"L Alessandrini","year":"2018","unstructured":"Alessandrini L, Manchi M, De Re V, et al. Proposed molecular and miRNA classification of gastric cancer. Int J Mol Sci. 2018;19(6):1683.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"4032_CR7","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1093\/nar\/gkw116","volume":"44","author":"N Ludwig","year":"2016","unstructured":"Ludwig N, Leidinger P, Becker K, et al. Distribution of MiRNA expression across human tissues. Nucleic Acids Res. 2016;44(8):3865\u201377. https:\/\/doi.org\/10.1093\/nar\/gkw116.","journal-title":"Nucleic Acids Res"},{"key":"4032_CR8","doi-asserted-by":"publisher","unstructured":"Zealy RW, Wrenn SP, Davila S, et al. microRNA-binding proteins: specificity and function.wiley. Interdiscip Rev RNA. 2017;8(5). https:\/\/doi.org\/10.1002\/wrna.1414.","DOI":"10.1002\/wrna.1414"},{"key":"4032_CR9","doi-asserted-by":"publisher","first-page":"849","DOI":"10.2147\/OTT.S180021","volume":"12","author":"M Deng","year":"2019","unstructured":"Deng M, Qin Y, Chen X, et al. MiR-206 inhibits proliferation, migration, and invasion of gastric cancer cells by targeting the MUC1 gene. Onco Targets Ther. 2019;12:849\u201359. https:\/\/doi.org\/10.2147\/OTT.S180021.","journal-title":"Onco Targets Ther"},{"key":"4032_CR10","doi-asserted-by":"crossref","unstructured":"Lei C, Du F, Sun L,et al.miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by suppressing MYO6.Cell Death Dis. 2017;8(10):e3101.doi: 10.1038\/cddis.2017.493.","DOI":"10.1038\/cddis.2017.493"},{"issue":"5","key":"4032_CR11","doi-asserted-by":"publisher","first-page":"567","DOI":"10.7150\/ijbs.7.567","volume":"7","author":"SL Guo","year":"2011","unstructured":"Guo SL, Peng Z, Yang X, et al. MiR-148a promoted cell proliferation by targeting p27 in gastric cancer cells. Int J Biol Sci. 2011;7(5):567\u201374. https:\/\/doi.org\/10.7150\/ijbs.7.567.","journal-title":"Int J Biol Sci"},{"issue":"24","key":"4032_CR12","doi-asserted-by":"publisher","first-page":"14596","DOI":"10.1111\/jcmm.16089","volume":"24","author":"X Zhang","year":"2020","unstructured":"Zhang X, Xue C, Cui X, Zhou Z, Fu Y, Yin X, et al. Circ_0075829 facilitates the progression of pancreatic carcinoma by sponging miR-1287-5p and activating LAMTOR3 signalling. J Cell Mol Med. 2020;24(24):14596\u2013607. https:\/\/doi.org\/10.1111\/jcmm.16089.","journal-title":"J Cell Mol Med"},{"key":"4032_CR13","doi-asserted-by":"publisher","first-page":"9229","DOI":"10.1002\/jcb.27190","volume":"119","author":"J Lu","year":"2018","unstructured":"Lu J, Tang L, Xu Y, et al. Mir-1287 suppresses the proliferation, invasion, and migration in hepatocellular carcinoma by targeting PIK3R3. J Cell Biochem. 2018;119:9229\u201338.","journal-title":"J Cell Biochem"},{"issue":"1","key":"4032_CR14","doi-asserted-by":"publisher","first-page":"e0314745","DOI":"10.1371\/journal.pone.0314745","volume":"20","author":"H Liu","year":"2025","unstructured":"Liu H, Karsidag M, Chhatwal K, Wang P, Tang T. Single-cell and bulk RNA sequencing analysis reveals CENPA as a potential biomarker and therapeutic target in cancers. PLoS ONE. 2025;20(1):e0314745. https:\/\/doi.org\/10.1371\/journal.pone.0314745.","journal-title":"PLoS ONE"},{"key":"4032_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.17352\/gjct","volume":"6","author":"H Liu","year":"2020","unstructured":"Liu H. Nav channels in cancers: nonclassical roles. Glob J Cancer Ther. 2020;6:5. https:\/\/doi.org\/10.17352\/gjct.","journal-title":"Glob J Cancer Ther"},{"issue":"6","key":"4032_CR16","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.19852\/j.cnki.jtcm.20220815.005","volume":"42","author":"L Hengrui","year":"2022","unstructured":"Hengrui L. Toxic medicine used in traditional Chinese medicine for cancer treatment: are ion channels involved?J. Tradit Chin Med. 2022;42(6):1019\u201322. https:\/\/doi.org\/10.19852\/j.cnki.jtcm.20220815.005.","journal-title":"Tradit Chin Med"},{"issue":"4","key":"4032_CR17","doi-asserted-by":"publisher","first-page":"326","DOI":"10.2174\/1574892817666220119121204","volume":"17","author":"Z Jin","year":"2022","unstructured":"Jin Z, Zhang W, Liu H, et al. Potential therapeutic application of local anesthetics in cancer treatment. Recent Pat Anticancer Drug Discov. 2022;17(4):326\u201342. https:\/\/doi.org\/10.2174\/1574892817666220119121204.","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"4032_CR18","doi-asserted-by":"publisher","unstructured":"Ou L, Zhu Z, Hao Y et al. 1,3,6-Trigalloylglucose: A novel potent Anti- Helicobacter pylori adhesion agent derived from aqueous extracts of terminalia chebula retz.molecules. 2024;29(5):1161. https:\/\/doi.org\/10.3390\/molecules29051161","DOI":"10.3390\/molecules29051161"},{"key":"4032_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1416794","volume":"15","author":"L Ou","year":"2024","unstructured":"Ou L, Hao Y, Liu H, et al. Chebulinic acid isolated from aqueous extracts of terminalia chebula Retz inhibits helicobacter pylori infection by potential binding to Cag A protein and regulating adhesion. Front Microbiol. 2024;15:1416794. https:\/\/doi.org\/10.3389\/fmicb.2024.1416794.","journal-title":"Front Microbiol"},{"key":"4032_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107558","volume":"212","author":"H Liu","year":"2020","unstructured":"Liu H, Dilger JP, Lin J. Effects of local anesthetics on cancer cells. Pharmacol Ther. 2020;212:107558. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107558.","journal-title":"Pharmacol Ther"},{"issue":"8","key":"4032_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23772","volume":"38","author":"J Wang","year":"2024","unstructured":"Wang J, Zhang Z, Zhuang J, Kang D, Song W. CircCOL5A1 is involved in proliferation, invasion, and inhibition of ferroptosis of colorectal cancer cells via miR-1287-5p\/SLC7A11. J Biochem Mol Toxicol. 2024;38(8):e23772. https:\/\/doi.org\/10.1002\/jbt.23772.","journal-title":"J Biochem Mol Toxicol"},{"issue":"1","key":"4032_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-024-00549-x","volume":"29","author":"M Jin","year":"2024","unstructured":"Jin M, Yuan T, Tian K, Li J, Huang Q, Chi Y, et al. Oncogenic circ-SLC16A1 promotes progression of non-small cell lung cancer via regulation of the miR-1287-5p\/profilin 2 axis. Cell Mol Biol Lett. 2024;29(1):43. https:\/\/doi.org\/10.1186\/s11658-024-00549-x.","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"4032_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12935-024-03228-1","volume":"24","author":"H Wang","year":"2024","unstructured":"Wang H, Zhang Y, Miao H, Xu T, Nie X, Cheng W. Circrad23b promotes proliferation and carboplatin resistance in ovarian cancer cell lines and organoids. Cancer Cell Int. 2024;24(1):42. https:\/\/doi.org\/10.1186\/s12935-024-03228-1.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"4032_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13058-019-1104-5","volume":"21","author":"D Schwarzenbacher","year":"2019","unstructured":"Schwarzenbacher D, Klec C, Pasculli B, Cerk S, Rinner B, Karbiener M, et al. MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors. Breast Cancer Res. 2019;21(1):20. https:\/\/doi.org\/10.1186\/s13058-019-1104-5.","journal-title":"Breast Cancer Res"},{"key":"4032_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.935155","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Chen B, Xiao M, Wang X, Peng Y. Brucea javanica oil emulsion promotes autophagy in ovarian cancer cells through the miR-8485\/LAMTOR3\/mTOR\/ATG13 signaling axis. Front Pharmacol. 2022;13:935155. https:\/\/doi.org\/10.3389\/fphar.2022.935155.","journal-title":"Front Pharmacol"},{"key":"4032_CR26","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1126\/science.281.5383.1668","volume":"281","author":"HJ Schaeffer","year":"1998","unstructured":"Schaeffer HJ, Catling AD, Eblen ST, Collier LS, Krauss A, Weber MJ. MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science. 1998;281:1668\u201371. https:\/\/doi.org\/10.1126\/science.281.5383.1668.","journal-title":"Science"},{"key":"4032_CR27","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.cell.2010.02.024","volume":"141","author":"Y Sancak","year":"2010","unstructured":"Sancak Y, Bar-Peled L, Zoncu R, Markhard AL, Nada S, Sabatini DM. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell. 2010;141:290\u2013303. https:\/\/doi.org\/10.1016\/j.cell.2010.02.024.","journal-title":"Cell"},{"key":"4032_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1478-811X-10-18","volume":"10","author":"M Marina","year":"2012","unstructured":"Marina M, Wang L, Conrad SE. The scaffold protein MEK partner 1 is required for the survival of Estrogen receptor positive breast cancer cells. Cell Commun Signal. 2012;10:18. https:\/\/doi.org\/10.1186\/1478-811X-10-18.","journal-title":"Cell Commun Signal"},{"issue":"2","key":"4032_CR29","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.celrep.2013.09.026","volume":"5","author":"S Jun","year":"2013","unstructured":"Jun S, Lee S, Kim HC, Ng C, Schneider AM, Ji H, et al. PAF-mediated MAPK signaling hyperactivation via LAMTOR3 induces pancreatic tumorigenesis. Cell Rep. 2013;5(2):314\u201322. https:\/\/doi.org\/10.1016\/j.celrep.2013.09.026.","journal-title":"Cell Rep"},{"issue":"9","key":"4032_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24648","volume":"36","author":"Y Gong","year":"2022","unstructured":"Gong Y, Lv Y, Xu F, Xiu Y, Lu Y, Liu Z, et al. LAMTOR3 is a prognostic biomarker in kidney renal clear cell carcinoma. J Clin Lab Anal. 2022;36(9):e24648. https:\/\/doi.org\/10.1002\/jcla.24648.","journal-title":"J Clin Lab Anal"},{"key":"4032_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1478-811X-7-26","volume":"7","author":"ER Park","year":"2009","unstructured":"Park ER, Pullikuth AK, Bailey EM, Mercante DE, Catling AD. Differential requirement for MEK partner 1 in DU145 prostate cancer cell migration. Cell Commun Signal. 2009;7:26. https:\/\/doi.org\/10.1186\/1478-811X-7-26.","journal-title":"Cell Commun Signal"},{"key":"4032_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.canlet.2017.05.019","volume":"403","author":"OS Kwon","year":"2017","unstructured":"Kwon OS, Hong SK, Kwon SJ, Go YH, Oh E, Cha HJ. Bcl2 induced by LAMTOR3\/MAPK is a druggable target of chemoradioresistance in mesenchymal lung cancer. Cancer Lett. 2017;403:48\u201358. https:\/\/doi.org\/10.1016\/j.canlet.2017.05.019.","journal-title":"Cancer Lett"},{"key":"4032_CR33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12935-020-01245-4","volume":"20","author":"ZZ Liang","year":"2020","unstructured":"Liang ZZ, Guo C, Zou MM, Meng P, Zhang TT. Circrna-mirna-mrna regulatory network in human lung cancer: an update. Cancer Cell Int. 2020;20:173. https:\/\/doi.org\/10.1186\/s12935-020-01245-4.","journal-title":"Cancer Cell Int"},{"issue":"22","key":"4032_CR34","doi-asserted-by":"publisher","first-page":"11650","DOI":"10.26355\/eurrev_202011_23809","volume":"24","author":"KY Shi","year":"2020","unstructured":"Shi KY, Fan LY, Xu D, Ren LP, Wang LP, Chen LY, et al. MiR-20a suppresses proliferation and facilitates apoptosis of breast cancer cells via the MTOR signaling pathway. Eur Rev Med Pharmacol Sci. 2020;24(22):11650\u20137. https:\/\/doi.org\/10.26355\/eurrev_202011_23809.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"4032_CR35","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2022.12646","volume":"25","author":"SM Lee","year":"2022","unstructured":"Lee SM, Park MS, Park SY, et al. Primary bile acid activates Egr-1 expression through the MAPK signaling pathway in gastric cancer. Mol Med Rep. 2022;25(4):129. https:\/\/doi.org\/10.3892\/mmr.2022.12646.","journal-title":"Mol Med Rep"},{"key":"4032_CR36","doi-asserted-by":"publisher","unstructured":"Lin TS, Huang WN, Yang JL et al. Allyl isothiocyanate inhibits cell migration and invasion in human gastric cancer AGS cells via affecting PI3K\/AKT and MAPK signaling pathway in vitro.environ toxicol. 2023;38(10):2287\u201397. https:\/\/doi.org\/10.1002\/tox.23864","DOI":"10.1002\/tox.23864"},{"issue":"1","key":"4032_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.112956","volume":"410","author":"J Pandian","year":"2022","unstructured":"Pandian J, Ganesan K. Delineation of gastric tumors with activated ERK\/MAPK signaling cascades for the development of targeted therapeutics. Exp Cell Res. 2022;410(1):112956. https:\/\/doi.org\/10.1016\/j.yexcr.2021.112956.","journal-title":"Exp Cell Res"},{"issue":"5","key":"4032_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e26852","volume":"10","author":"L Chen","year":"2024","unstructured":"Chen L, Huang F, Luo X, Chen Z. TREM1 promotes cancer associated malignant phenotype through activated MAPK signaling pathway and predicts poor prognosis in gastric cancer. Heliyon. 2024;10(5):e26852. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26852.","journal-title":"Heliyon"},{"issue":"8","key":"4032_CR39","first-page":"4074","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H. Pan-cancer profiles of the cuproptosis gene set. Am J Cancer Res. 2022;12(8):4074\u201381.","journal-title":"Am J Cancer Res"},{"key":"4032_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.952290","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H, Tang T. Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set. Front Oncol. 2022;12:952290. https:\/\/doi.org\/10.3389\/fonc.2022.952290.","journal-title":"Front Oncol"},{"key":"4032_CR41","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cancergen.2023.10.001","volume":"278","author":"H Liu","year":"2023","unstructured":"Liu H, Tang T. Pan-cancer genetic analysis of disulfidptosis-related gene set. Cancer Genet. 2023;278:91\u2013103. https:\/\/doi.org\/10.1016\/j.cancergen.2023.10.001.","journal-title":"Cancer Genet"},{"key":"4032_CR42","doi-asserted-by":"publisher","unstructured":"Rasteh AM, Liu H, Wang P. Pan-cancer genetic profiles of mitotic DNA integrity checkpoint protein kinases.cancer biomark. 2024;41(3\u20134):CBM240119. https:\/\/doi.org\/10.3233\/CBM-240119","DOI":"10.3233\/CBM-240119"},{"key":"4032_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2025.107646","volume":"205","author":"RM Mansour","year":"2025","unstructured":"Mansour RM, El-Sayyad GS, Abulsoud AI, et al. The role of MiRNAs in pathogenesis, diagnosis, and therapy of Helicobacter pylori infection, gastric cancer-causing bacteria: special highlights on nanotechnology-based therapy. Microb Pathog. 2025;205:107646. https:\/\/doi.org\/10.1016\/j.micpath.2025.107646.","journal-title":"Microb Pathog"},{"key":"4032_CR44","doi-asserted-by":"publisher","unstructured":"Tian J, Wang Z, Ren Y et al. Rapamycin attenuates anxiety and depressive behavior induced by Helicobacter pylori in association with reduced Circulating levels of ghrelin.neural plast. 2022;2022:2847672. https:\/\/doi.org\/10.1155\/2022\/2847672","DOI":"10.1155\/2022\/2847672"},{"issue":"9","key":"4032_CR45","doi-asserted-by":"publisher","first-page":"14800","DOI":"10.1002\/jcp.28279","volume":"234","author":"M Eslami","year":"2019","unstructured":"Eslami M, Yousefi B, Kokhaei P, Arabkari V, Ghasemian A. Current information on the association of Helicobacter pylori with autophagy and gastric cancer. J Cell Physiol. 2019;234(9):14800\u201311. https:\/\/doi.org\/10.1002\/jcp.28279.","journal-title":"J Cell Physiol"},{"issue":"3","key":"4032_CR46","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/ot9.0000000000000039","volume":"10","author":"RM Joshi","year":"2024","unstructured":"Joshi RM, Telang B, Soni G. A khalife.overview of perspectives on cancer,newer therapies,and future directions.oncology and. Translational Med. 2024;10(3):105\u20139. https:\/\/doi.org\/10.1097\/ot9.0000000000000039.","journal-title":"Translational Med"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04032-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-04032-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04032-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T01:03:12Z","timestamp":1760490192000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-04032-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4032"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-04032-5","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review boards of The Second Hospital of Hebei Medical University(No.2024-R445). All the experiments in this study were carried out in accordance with relevant guidelines and regulation for human study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all participants or their clients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"370"}}